Tempest TherapeuticsTPST
13F holders, Q1 2025 (March 31)2holders
$0.74avg. 13F price*
At the end of Q1 2025, 2 institutions reported holding Tempest Therapeutics Inc. (TPST) in their 13F filings. The largest holders were Versant Venture Management, LLC ($2.6M) and SBI Securities Co., Ltd. ($566).
- Company
- Tempest Therapeutics Inc.
- CUSIP
- 87978U207
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $2.6M |
| Exits | 0 | $0 |
Ownership 2 holders
| Versant Venture Management, LLC | 4.30% | New | 3,507,055 | $2.6M |
| SBI Securities Co., Ltd. | 0.00% | New | 767 | $566 |
"% of holder's portfolio" is TPST's weight in each manager's 13F, not the share of Tempest Therapeutics Inc. the manager owns.